encevis (2.1)

AIT Austrian Institute of Technology GmbH · K240993 · 2024-09-27

encevis (2.1) is an AI-enabled medical device from AIT Austrian Institute of Technology GmbH, listed by FDA (510(k), K240993) with a decision date of 2024-09-27. Review panel: Neurology.

FDA submission numberK240993
Pathway510(k)
CompanyAIT Austrian Institute of Technology GmbH
Review panel (specialty)Neurology
FDA decision date2024-09-27
DecisionSubstantially Equivalent
Product codeOMB
ClassificationAutomatic Event Detection Software For Full-Montage Electroencephalograph
Device class2
Regulation number882.1400
Review time (calendar days)169
Applicant countryAT

Official FDA database record · FDA AI-enabled device list

All Neurology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.